Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1361-1380 of 3,190 trials

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

NCT00888927

This study will determine the maximum dose of KW-0761 administered intravenously that can be given safely in subjects with previously treated peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma(CTCL)and will see if it is effective in treating the disease.

Peripheral T-Cell Lymphoma

Kyowa Kirin Co., Ltd.42 participantsStarted May 2009

Los Angeles, California, United States • Stanford, California, United States • New Haven, Connecticut, United States +2 more locations

COMPLETED< 1 mile

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

NCT04351893

The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.

MicrotiaMicrotia-AnotiaCraniofacial Microsomia+4 more

Seattle Children's Hospital935 participantsStarted Feb 2018

Los Angeles, California, United States • Chapel Hill, North Carolina, United States • Philadelphia, Pennsylvania, United States +7 more locations

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

Rheumatoid Arthritis Trials in Other Cities

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Safety and Effectiveness Study of the Zenflow Spring System

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Acupuncture for PTSD

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Brain Oxygenation-II

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Other Conditions in Los Angeles